Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension

Marina Shargorodsky, Eyal Leibovitz, Leonid Lubimov, Dov Gavish, Reuven Zimlichman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences